The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 1st 2025
In clinical trials, the dihydroergotamine (DHE) nasal powder had favorable safety profiles and rapid pain relief in patients with migraine with or without aura.
Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration
August 5th 2015Allergan plc and KYTHERA Biopharmaceuticals, Inc. today announced that they have amended and restated their merger agreement with respect to Allergan's pending acquisition of KYTHERA.
Read More